Incidence and Survival Changes in Patients with Esophageal Adenocarcinoma during 1984–2013
Table 1
Relative survival rates of EAC during 1984–1993, 1994–2003, and 2004–2013 at eighteen SEER sites.
Age group
Decade
1984–1993
1994–2003
2004–2013
6-Mo RSR
All
63.2 ± 1 (2584)
66.0 ± 0.5 (9196)
70.3 ± 0.4 (18111)
20–44
66.8 ± 4.6 (105)
74.1 ± 2.2 (409)
75.3 ± 1.8 (622)
45–54
78.0 ± 2.4 (311)
71.4 ± 1.2 (1398)
75.2 ± 0.9 (2550)
55–64
68.8 ± 1.8 (699)
71.9 ± 0.9 (2316)
75.0 ± 0.6 (5469)
65–74
58.3 ± 1.7 (852)
66.6 ± 0.9 (2692)
73.4 ± 0.7 (4946)
75+
55.5 ± 2.1 (617)
55.0 ± 1.1 (2381)
57.5 ± 0.8 (4524)
12-Mo RSR
All
39.2 ± 1.0
45.8 ± 0.5
50.8 ± 0.4
20–44
37.2 ± 4.7
52.3 ± 2.5
55.0 ± 2.1
45–54
49.0 ± 2.9
50.0 ± 1.3
54.8 ± 1.0
55–64
44.0 ± 1.9
51.1 ± 1.1
55.9 ± 0.7
65–74
35.6 ± 1.7
46.8 ± 1.0
53.5 ± 0.8
75+
33.9 ± 2.0
35.6 ± 1.0
38.6 ± 0.8
24-Mo RSR
All
20.9 ± 0.8
28.7 ± 0.5
33.3 ± 0.4
20–44
21.1 ± 4
29.3 ± 2.3
32.7 ± 2
45–54
24.8 ± 2.5
31.1 ± 1.2
35.4 ± 1
55–64
23.5 ± 1.6
33.3 ± 1
37.6 ± 0.7
65–74
19.8 ± 1.4
30.2 ± 0.9
36.1 ± 0.8
75+
17.1 ± 1.7
20.5 ± 0.9
23.7 ± 0.7
36-Mo RSR
All
14.7 ± 0.7
22.1 ± 0.5
25.8 ± 0.4
20–44
14.4 ± 3.4
21.7 ± 2.1
25.1 ± 1.9
45–54
17.4 ± 2.2
24.1 ± 1.2
28.6 ± 1
55–64
17.3 ± 1.5
26.4 ± 0.9
28.8 ± 0.7
65–74
14.2 ± 1.3
23.1 ± 0.9
28.3 ± 0.8
75+
11.0 ± 1.5
15.4 ± 0.9
17.9 ± 0.7
48-Mo RSR
All
12.1 ± 0.7
18.6 ± 0.4
22.4 ± 0.4
20–44
12.5 ± 3.2
18.7 ± 2
20.5 ± 1.8
45–54
15.2 ± 2.1
21.0 ± 1.1
25.2 ± 1
55–64
13.7 ± 1.4
22.1 ± 0.9
25.2 ± 0.7
65–74
12.0 ± 1.2
19.1 ± 0.8
25.3 ± 0.8
75+
8.3 ± 1.3
12.8 ± 0.8
14.1 ± 0.7
60-Mo RSR
All
10.9 ± 0.7
16.8 ± 0.4
20.1 ± 0.4
20–44
11.6 ± 3.1
17.0 ± 1.9
19.4 ± 1.8
45–54
13.7 ± 2
19.7 ± 1.1
22.7 ± 1
55–64
12.1 ± 1.3
19.7 ± 0.9
22.6 ± 0.7
65–74
10.7 ± 1.2
17.4 ± 0.8
22.7 ± 0.8
75+
7.9 ± 1.3
10.9 ± 0.8
12.6 ± 0.7
Data are mean ± standard error of the mean, with number of patients in parentheses. Mo, month; RSR, relative survival rate; SEM, standard error of the mean. ,, and for comparisons with the preceding decade.
